![]()

In this month’s PME, Lucid CEO and co-founder, Dennis
O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’.
In response to the increasing demands of global healthcare
systems, pharma must demonstrate its value contribution. It is responding with
patient-centric corporate missions, and patient outcomes-driven visions and
initiatives, all with the aim of improving patient outcomes.
Dennis and Louise discuss how it’s no longer good enough to
prove a commitment to patient outcomes, but instead we must demonstrate an impact. The programmes and initiatives that
are incorporated into cross-functional plans all need to align to the same goal
– so that we can then measure their impact against improving patient outcomes.
The vision is there, but it requires translation of this
vision to execution of outcomes-led strategic planning, cross-functional
alignment and metrics collection that transcend annual key performance
indicator cycles.
You can read more in the full article
here